How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/hydrochloride-hydromorphone-flurbiprofen-axetil.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-18 · How we verify

hydrochloride hydromorphone + flurbiprofen axetil — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

hydrochloride hydromorphone + flurbiprofen axetil (hydrochloride hydromorphone + flurbiprofen axetil) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Opioid analgesic + NSAID combination. Area: Pain Management.

marketed Opioid analgesic + NSAID combination Mu-opioid receptor (hydromorphone); COX-1/COX-2 (flurbiprofen axetil) Pain Management Small molecule Live · refreshed every 30 min

Target snapshot

hydrochloride hydromorphone + flurbiprofen axetil (hydrochloride hydromorphone + flurbiprofen axetil) — First Affiliated Hospital, Sun Yat-Sen University. This combination drug provides opioid analgesia via hydromorphone and anti-inflammatory pain relief via flurbiprofen axetil to manage moderate to severe pain.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
hydrochloride hydromorphone + flurbiprofen axetil TARGET	hydrochloride hydromorphone + flurbiprofen axetil	First Affiliated Hospital, Sun Yat-Sen University	marketed	Opioid analgesic + NSAID combination	Mu-opioid receptor (hydromorphone); COX-1/COX-2 (flurbiprofen axetil)
morphine ,ketorolac	morphine ,ketorolac	Jose Antonio Bernia Gil	marketed	Opioid analgesic + NSAID combination	Opioid receptors (μ, δ, κ); COX-1 and COX-2 enzymes

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Opioid analgesic + NSAID combination class)

First Affiliated Hospital, Sun Yat-Sen University · 1 drug in this class
Jose Antonio Bernia Gil · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). hydrochloride hydromorphone + flurbiprofen axetil — Competitive Intelligence Brief. https://druglandscape.com/ci/hydrochloride-hydromorphone-flurbiprofen-axetil. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab